Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma

Chronobiology International - Tập 33 Số 2 - Trang 210-219 - 2016
Feng‐Ming Hsu1, Chia‐Chun Wang2, Chao‐Yuan Huang3, Chiao‐Ling Tsai1, Yu‐Chieh Tsai4, Hong‐Jeng Yu3, Yeong‐Shiau Pu3, Jason Chia‐Hsien Cheng1,5
1a Division of Radiation Oncology, Department of Oncology , National Taiwan University Hospital , Taipei , Taiwan.
2b Department of Radiation Oncology , City of Hope Cancer Center , Duarte , California , USA.
3c Department of Urology , National Taiwan University College of Medicine , Taipei , Taiwan.
4d Division of Medical Oncology, Department of Oncology , National Taiwan University Hospital , Taipei , Taiwan.
5e Graduate Institute of Oncology, National Taiwan University College of Medicine , Taipei , Taiwan.

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.3109/07420528.2011.569043

Al Mheid I, 2014, J Am Heart Assoc, 15

10.1016/j.ijrobp.2009.04.033

10.3109/07420528.2014.901347

10.1002/cncr.28237

10.3109/13685539809146107

10.1016/j.ijrobp.2008.07.009

Brown SA, Schmitt K, Eckert A. (2011). Aging and circadian disruption: Causes and effects Vol 3. Albany, NY: Aging. pp. 813–7.

KN Buchi, 1991, Gastroenterology, 101, 410, 10.1016/0016-5085(91)90019-H

10.1210/en.2011-1842

10.1158/0008-5472.CAN-08-4199

10.1097/01.MP.0000032529.68297.B2

10.1093/jnci/djt169

10.1093/annonc/mds148

10.1080/09553000902883802

10.1016/j.yhbeh.2012.09.006

10.1081/CBI-120002592

10.1093/pan/mpl013

10.3109/07853890.2014.916990

10.1038/73943

Jung-Hynes B, 2010, J Pineal Res, 49, 60

10.1016/j.ijrobp.2007.06.054

10.1161/ATVBAHA.111.237651

Levi F, 1997, fluorouracil, and folinic acid in metastatic colorectal cancer. Int Organiz Cancer Chronotherapy Lancet, 350, 681

10.1158/0008-5472.CAN-13-1528

10.1016/j.yhbeh.2015.05.007

Mormont MC, Waterhouse J, Bleuzen P, et al, 2000, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res, 6, 3038

Noh JM, 2014, J Radiat Res, 132, 618

10.1016/j.dnarep.2015.02.002

10.1126/science.1060191

10.1200/JCO.2005.05.2530

10.1146/annurev.ph.55.030193.000313

10.1002/cncr.25423

10.1038/nature00965

10.1002/cncr.24348

10.1016/j.smrv.2007.07.005

10.1002/cncr.24867

Sothern RB, 1995, FASEB J, 9, 397, 10.1096/fasebj.9.5.7896010

10.1160/TH09-06-0386

10.18632/oncotarget.3179

10.1016/j.ijrobp.2013.05.047

10.1158/0008-5472.CAN-09-0648

10.1200/JCO.2009.25.8475